Thermo Fisher Scientific Inc. (TMO)

Thermo Fisher Scientific Inc. (TMO) is a healthcare company (diagnostics & research) based in the United States. The share price is $691.29, down 0.01% on the day, which values the company at $256.13B. Price as of 17 Nov 2026, 17:37 UTC, from Yahoo Finance.

Key facts

Share price
$691.29−0.01% today
Market value
$256.13B
P/E ratio
36.5×last 12 months
Forward P/E
24.9×
Dividend yield
0.27%
Funk Score
37/100
Against its own history
Well above its usual priceusual price $389.51
200-week average
$538.8428% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Thermo Fisher Scientific Inc. in more detail

TMO trades at 36.5× its last twelve months' earnings, 24.9× next year's expected earnings, 5.4× sales. Measured against its own history, the price is 77% above what its usual multiples would imply ($389.51) — well above its usual price. It sits 28% above its 200-week average of $538.84.

Over the last five fiscal years Thermo Fisher Scientific Inc. has compounded revenue 6.7% a year, earnings per share 2.1% a year, free cash flow -1.6% a year. Its Funk Score is 37 out of 100 (financial strength 4.6, profitability 5.1, growth 3.2, value 1.9, each out of 10).

In its favour: Altman Z in the safe zone; Share count keeps falling. Worth checking: Debt is growing faster than cash flow.

24 of the superinvestors tracked here hold TMO, including Nick Train (12.4% of the portfolio), Larry Robbins (6.3% of the portfolio), Wallace Weitz (4.9% of the portfolio).

Superinvestors holding TMO

24 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:TMO vs AMGN (Thermo Fisher Scientific Inc. vs Amgen)TMO vs AZN (Thermo Fisher Scientific Inc. vs AstraZeneca)TMO vs NVS (Thermo Fisher Scientific Inc. vs Novartis)TMO vs GILD (Thermo Fisher Scientific Inc. vs Gilead Sciences)TMO vs UNH (Thermo Fisher Scientific Inc. vs UnitedHealth Group)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Thermo Fisher Scientific Inc. (TMO): questions and answers

What is TMO's P/E ratio?

Thermo Fisher Scientific Inc. trades at 36.5× its last twelve months' earnings and 24.9× next year's expected earnings. At its fiscal year-ends over the past 19 years the P/E ranged from 13.0× to 35.4×, with a median of 30.9×.

What is TMO's PEG ratio?

Thermo Fisher Scientific Inc.'s PEG ratio is 2.03 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Thermo Fisher Scientific Inc.'s market cap?

Thermo Fisher Scientific Inc. is valued at $256.13B at a share price of $691.29.

Is TMO overvalued or undervalued?

Against its own history, TMO is well above its usual price: the price is 77% above the $389.51 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is TMO above its 200-week moving average?

Yes. TMO is 28.3% above its 200-week average of $538.84. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Thermo Fisher Scientific Inc. growing?

Over the last five fiscal years Thermo Fisher Scientific Inc.'s revenue grew 6.7% a year and its earnings per share 2.1% a year; over ten years revenue grew 10.1% a year.

Cite this page

Funkfolio, “Thermo Fisher Scientific Inc. (TMO) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/TMO

Underlying data: Yahoo Finance; company filings with the SEC.